The FDA has now approved Eli Lilly's new drug, Cymbalta, for treatment of depression. The new drug is expected to generate peak annual sales of about $2 billion, and is being described as a "much-needed boon for Eli Lilly after the sales of its former top-selling antidepressant Prozac fell due to generic...

Original Article: New Antidepressant Drug Approved, But It's All About Profits, Not Helping Patients

Notice: The preceding article was not written by a member of the Anti-Aging Revolution. This article is provided for informational and reference purposes only. The Anti-Aging Revolution cannot guarantee the stability of third-party outside links.